⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NKTX News
Nkarta, Inc. Common Stock
Form 8-K
sec.gov
NKTX
Nkarta Reports First Quarter 2026 Financial Results and Corporate Highlights
globenewswire.com
NKTX
Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers
globenewswire.com
NKTX
Nkarta to Participate in Needham Virtual Healthcare Conference
globenewswire.com
NKTX
Form 8-K
sec.gov
NKTX
Form 8-K
sec.gov
NKTX
Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights
globenewswire.com
NKTX
Nkarta to Participate in March Investor Conferences
globenewswire.com
NKTX
NÖK Therapeutics to Participate in BIO Investment & Growth Summit in Miami
globenewswire.com
NKTX
Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer
globenewswire.com
ABEO
NKTX